Download 2016 Reviewing Codes One (1) Reviewing Code that best describes

2016 Reviewing Codes
One (1) Reviewing Code that best describes the content of your abstract
must be selected during submission.
1200 accommodation and presbyopia, in vivo and in vitro VI
1210 adaptive optics: imaging - VI
1220 adaptive optics: visual function - VI
1230 allergic conjunctivitis - IM
1240 amblyopia - EY
1250 amblyopia: animal models and basic mechanisms - EY
1260 amblyopia: screening and epidemiology - EY
1270 AMD anti VEGF - RE
1280 AMD imaging - RE
1290 AMD novel therapies (i.e. except anti-VEGF) - RE
1300 AMD: biochemical and molecular disease
mechanisms - BI
1310 AMD: cell biology - RC
1320 AMD: clinical research - RE
1330 AMD: epidemiology - CL
1340 AMD: genetic studies - GEN
1350 AMD: immunobiology - IM
1360 AMD: new drugs, delivery systems, and mechanisms
of action - PH
1370 AMD: pathology - RC
1380 AMD: preclinical studies - RC
1390 AMD: translational studies - RE
1400 anatomy: ocular structures excepting cornea, lens,
retina - AP
1410 anatomy: orbital structures excepting extraocular
muscles - AP
1420 angiogenesis - RC
1430 anterior segment epidemiology (non-cornea) - CL
1440 antiangiogenic agents - PH
1450 antibiotics/antivirals - PH
1460 anti-inflammatory agents - PH
1470 aqueous humor dynamics - PH
1480 artificial vision, nanobiodevices, manipulation and
engineering - NT
1490 autoimmune ocular disease - IM
1500 bacterial/parasitic infections - IM
1510 binocular vision or stereopsis - VI
1520 bipolar cell structure and function - VN
1530 blood flow - PH
1540 cataract surgery - LE
1550 cataract surgery: epidemiology - LE
1560 cataract surgery: surgical procedures - LE
1570 cataract: epidemiology - CL
1580 cataractogenesis - LE
1590 choroid: cell biology and function - AP
1600 choroidal neovascularization - RE
1610 clinical trials: visual impairment and function - LV
1620 CNV: animal models and mechanisms - RC
1630 color vision - VI
1640 conjunctiva: cell biology, disease and surgery - CO
1650 contact lens - CO
1660 cornea surgery: refractive - CO
1670 corneal applied regenerative medicine - CO
1680 corneal biomechanics - CO
1690 corneal cell and molecular biology - CO
1700 corneal development and cell differentiation - CO
1710 corneal disease: epidemiology - CL
1720 corneal disease: pharmacology - PH
1730 corneal dystrophies and genetics - GEN
1740 corneal endothelium - CO
1750 corneal epithelium - CO
1760 corneal imaging and topography - CO
1770 corneal immunology - CO
1780 corneal immunology and infections - IM
1790 corneal neovascularization - CO
1800 corneal neuropathy: diabetic and other - CO
1810 corneal optics and myopia: optical quality - VI
1820 corneal surgery: non-refractive - CO
1830 corneal wound repair and healing - CO
1840 corneal: stroma and keratocytes - CO
1850 cytokines and growth factors - PH
1860 diabetic macular edema anti VEGF - RE
1870 diabetic macular edema: clinical research - RE
1880 diabetic retinopathy: angiogenesis - RC
1890 diabetic retinopathy: biochemical and molecular
disease mechanisms - BI
1900 diabetic retinopathy: cell biology - RC
1910 diabetic retinopathy: epidemiology - CL
1920 diabetic retinopathy: genetic studies - GEN
1
1930 diabetic retinopathy: medical - RE
1940 diabetic retinopathy: pharmacological agents, targets
and mechanisms of action - PH
1950 diabetic retinopathy: preclinical studies - RC
1960 diabetic retinopathy: surgical - RE
1970 drug and gene delivery systems - PH
1980 drug delivery: iris-ciliary body/intraocular
fluids/posterior segment - PH
1990 dry eye disease - CO
2000 electrophysiology - VN
2010 electroretinography of disease - VN
2020 electroretinography: basic mechanisms and
techniques - VN
2030 endophthalmitis: clinical - RE
2040 epigenetics and chromatin structure in ocular
function/disease - BI
2050 extraocular muscles and associated tissues - EY
2060 eye movements - EY
2070 eye movements: nystagmus - EY
2080 Fuchs corneal dystrophy pathobiology - CO
2090 functional consequences of vision loss - CL
2100 ganglion cell structure and function - VN
2110 gene editing - BI
2120 gene therapies - BI
2130 gene therapy and delivery - PH
2140 gene therapy: visual impairment and function - LV
2150 gene variants: sequencing, function, or phenotype - BI
2160 genetic epidemiology - CL
2170 genetics - GEN
2180 genome structure, functional/translational genomics,
transcriptomics - BI
2190 glaucoma: biochemistry and molecular biology,
genomics and proteomics - BI
2200 glaucoma: biomechanics - GL
2210 glaucoma: clinical drug studies and clinical trials - GL
2220 glaucoma: electrophysiology - GL
2230 glaucoma: epidemiology - CL
2240 glaucoma: genetics - GEN
2250 glaucoma: imaging - GL
2260 glaucoma: IOP measurement and characterization GL
2270 glaucoma: laser therapy - GL
2280 glaucoma: neurodegeneration - GL
2290 glaucoma: neuroprotection - GL
2300 glaucoma: ocular blood flow - GL
2310 glaucoma: pharmacological intervention or cellular
mechanism - GL
2320 glaucoma: structure/function relationships - GL
2330 glaucoma: surgery or wound healing - GL
2340 glaucoma: trabecular meshwork and ciliary body - GL
2350 glaucoma: visual fields and psychophysics - GL
2360 glaucoma: visual impairment and function – LV
2370 glial cells - RC
2380 health care delivery and economic research - CL
2390 horizontal and amacrine cells: structure and function VN
2400 hypoxia - PH
2410 imaging technology - VI
2420 imaging: adaptive optics - MOI
2430 imaging: animal models - MOI
2440 imaging: clinical applications - MOI
2450 imaging: functional imaging - MOI
2460 imaging: image processing and analysis
methodologies - MOI
2470 imaging: magnetic resonance imaging - MOI
2480 imaging: new technologies and techniques - MOI
2490 imaging: optical coherence tomography - MOI
2500 imaging: other - MOI
2510 imaging: posterior segment, clinical - RE
2520 imaging: ultrasound - MOI
2530 immunohistochemistry and other tissue-based
diagnostic techniques - AP
2540 implant delivery systems - PH
2550 inflammasome: cell and molecular biology - RC
2560 inflammation/infection and imaging - IM
2570 innate immunity to pathogens - IM
2580 intraocular pressure/physiology pharmacology - PH
2590 intravitreal/periocular local therapies - RE
2600 intrinsically photoreceptive ganglion cell structure
and function - VN
2610 IOL and crystalline lens optics - VI
2620 ion channels, aquaporins, membrane properties and
epithelial transport - PH
2630 ischemia/reperfusion and oxidative stress - PH
2640 keratoconus and collagen crosslinking - CO
2650 keratoprosthesis - CO
2660 laser - RE
2670 lens - LE
2680 lens accommodation - LE
2690 lens cytoskeleton - LE
2700 lens development and differentiation - LE
2710 lens physiology - LE
2720 lens proteins: normal and pathogenic biochemistry LE
2730 low vision: mobility and driving - LV
2740 low vision: questionnaires and quality of life -LV
2750 low vision: reading - LV
2760 low vision: understanding mechanisms - VI
2770 low vision: visual function - LV
2780 low vision: visual psychophysics - VI
2790 macular degeneration: inherited - RC
2800 macular diseases except AMD - RE
2810 macular edema - RE
2820 micelles, liposomes, microparticle and colloidal
delivery systems - PH
2830 microbiology/immunology translational - IM
2840 microglia / innate immunity - RC
2850 microtechnology - NT
2860 molecular and biochemical mechanisms of retinal
disease - BI
2870 molecular pharmacology / receptors / signal
transduction - PH
2
2880 myopia - AP
2890 myopia: animal models - AP
2900 myopia: epidemiology - CL
2910 myopia: genetics - AP
2920 myopia: imaging - AP
2930 myopia: molecular biology - AP
2940 myopia: structure/function relationships - AP
2950 nanoimaging, nanobiology, nanodiagnostics - NT
2960 nanomedicine, nanopharmaceuticals, nanotherapy NT
2970 nanoparticles, nanobiosensors, nanobiomarker,
nanophotonics, nanobioelectronics, nanofluids - NT
2980 neural retina: dysfunction in disease - VN
2990 neuronal repair and replacement - NT
3000 neuro-ophthalmology - EY
3010 neuro-ophthalmology: idiopathic intracranial
hypertension - EY
3020 neuro-ophthalmology: optic neuropathy excepting
glaucoma - EY
3030 neuro-ophthalmology: papilledema - EY
3040 neuro-ophthalmology: pupillometry - EY
3050 neuro-ophthalmology: visual fields and
psychophysics - EY
3060 neuro-ophthalmology: visual impairment and function
- LV
3070 neuroprotection - RC
3080 non-infectious uveitis - IM
3090 ocular development - AP
3100 ocular measurements: refractive
error/aberrations/ocular dimensions - VI
3110 ocular proteomics, lipidomics, metabolomics and
systems biology - BI
3120 ocular surface health and disease - CO
3130 ocular therapeutics and chemical biology - BI
3140 ocular toxicology - PH
3150 ocular trauma: epidemiology - CL
3160 oculoplastics - EY
3170 oculoplastics: basic mechanisms and animal models EY
3180 oculoplastics: therapeutic approaches and clinical
trials - EY
3190 optic nerve - EY
3200 optic nerve: structure/function relationships - EY
3210 optic neuritis - EY
3220 optical aberrations - VI
3230 optogenetics - VN
3240 orbital disease/surgery - EY
3250 pediatric ophthalmology: epidemiology - CL
3260 photoreceptor degeneration/apoptosis: cell biology
and pathology - RC
3270 photoreceptors: development - RC
3280 photoreceptors: structure and function - VN
3290 phototransduction and signalling in retina/RPE - BI
3300 physiological optics, optical design and optical
models - VI
3310 posterior capsular opacification (PCO) - LE
3320 proliferative vitreoretinopathy - RE
3330 protein interactions/ trafficking/ transfer and protein
modifications - BI
3340 ptosis - EY
3350 refractive error: animal models - AP
3360 refractive error: cell biology - AP
3370 refractive error: epidemiology - CL
3380 refractive error: molecular biology - AP
3390 refractive error: structure/function relationships - AP
3400 refractive error: imaging - AP
3410 regenerative medicine - NT
3420 regulation of ocular genes, microRNA/non-coding
RNA-mediated control - BI
3430 restoration of vision - NT
3440 retina/RPE: biochemistry and molecular biology - BI
3450 retina/RPE: cell biology - RC
3460 retina/RPE: cell death, autophagy, oxidation, ER
stress - RC
3470 retina/RPE: development - RC
3480 retina/RPE: genetic studies - GEN
3490 retina/RPE: new drugs, mechanisms of action, and
toxicity - PH
3500 retina/RPE: transplantation, clinical - RE
3510 retina: biochemistry and molecular biology (nonphotoreceptor) - AP
3520 retina: physiology/pharmacology - PH
3530 retinal (neural and RPE) degeneration - RC
3540 retinal adaptation, modulation and circadian rhythms VN
3550 retinal detachment: basic research - RE
3560 retinal detachment: clinical - RE
3570 retinal development, apoptosis and cell death - BI
3580 retinal development: cell biology and morphology RC
3590 retinal development: synaptic mechanisms and
circuitry - VN
3600 retinal disease: epidemiology - CL
3610 retinal diseases – visual impairment and function –
LV
3620 retinal image quality - VI
3630 retinal inflammation and infection - IM
3640 retinal prostheses - RE
3650 retinal prostheses: visual impairment and function LV
3660 retinal synapses: chemical and electrical - VN
3670 retinitis pigmentosa: clinical - RE
3680 retinoids and carotenoids: visual cycle and macular
pigment - BI
3690 retinopathy of prematurity: clinical - RE
3700 ROP-basic mechanisms - RC
3710 spatial vision - VI
3720 stem cells - RC
3730 strabismus - EY
3740 strabismus: basic mechanisms and animal models EY
3
3750 strabismus: therapeutic approaches and clinical trials EY
3760 tear film, lacrimal gland, and meibomian gland - CO
3770 temporal vision - VI
3780 thyroid eye disease - EY
3790 tissue bioengineering - NT
3800 trauma: cell and molecular biology - RC
3810 trauma: posterior segment, clinical - RE
3820 tumors: cell culture and animal models - AP
3830 tumors: eyelids, ocular surface, conjunctiva, and
ocular adnexa - AP
3840 tumors: genetic studies - GEN
3850 tumors: imaging and therapeutics - AP
3860 tumors: immunobiology - IM
3870 tumors: molecular diagnostics and pathology - AP
3880 tumors: orbit/NOS - AP
3890 tumors: retinoblastoma - AP
3900 tumors: uveal melanoma- AP
3910 uveitis: epidemiology, quality of life - IM
3920 uveitis: therapeutics - IM
3930 viral/fungal infections - IM
3940 visual adaptation - VI
3950 visual and retinal processing - VN
3960 visual behavior - VN
3970 visual development - VI
3980 visual evoked potentials - VN
3990 visual function and quality of life - CL
4000 visual function in normal and aging vision - VI
4010 visual function in presence of ocular disease - VI
4020 visual impairment: prevalence, incidence and risk
factors - CL
4030 visual psychophysics: fundamental and applied - VI
4040 vitreoretinal interface disease - RE
4050 vitreoretinal surgery: clinical - RE
4060 vitreoretinal surgery: novel approaches - RE
4